Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacteria on the eyelid margin" refers to the **normal microbial flora** that reside at the base of eyelashes and along the edge of the upper and lower lids. These bacteria are typically harmless but can become problematic if they proliferate excessively or if host defenses are compromised. Overgrowth is a key factor in conditions such as **blepharitis**, which is chronic inflammation of the lid margins characterized by irritation, redness, itching, burning sensations, crusting at lash bases, and sometimes secondary infection[1][2][3][4]. The most common bacteria implicated are *Staphylococcus* species[1][5]. This entity is **not a molecular target** such as a receptor or enzyme; rather it describes a population of microorganisms. Therefore it does not fit standard definitions for therapeutic targets used in drug discovery. Management focuses on reducing bacterial load through improved lid hygiene—warm compresses and scrubs—and topical/oral antibiotics when necessary[2][3][4]. While these interventions target bacteria generally present on the lid margins, there is no specific "bacterial receptor" being targeted. Because this entry refers to an entire group of organisms rather than a specific molecular entity or validated drug target structure/classification, it should be flagged as incorrect for structured pharmacological databases seeking canonical targets. > "Blepharitis...occurs when normal bacteria that live on your eyelids become over-populated..."[2] > "Blepharitis is usually caused by bacteria that live on the skin..."[4] > "Acute ulcerative blepharitis is usually caused by bacterial infection...of the eyelid margin at origins of eyelashes..."[5] In summary: “Bacteria on eyelid margin” describes commensal microbes whose overgrowth can cause disease but does not represent a canonical molecular drug target.
Antibiotics reduce bacterial load on the eyelid margins
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial colonization of eyelid margin.